JoVE Logo
Faculty Resource Center

Sign In

Summary

Abstract

Protocol

Representative Results

Discussion

References

Immunology and Infection

Generating Genetically Modified Plasmodium berghei Sporozoites

Published: May 5th, 2023

DOI:

10.3791/64992

1Center for Tropical and Emerging Global Diseases, University of Georgia, 2Department of Cellular Biology, University of Georgia

Malaria is transmitted through inoculation of the sporozoite stage of Plasmodium by infected mosquitoes. Transgenic Plasmodium has allowed us to understand the biology of malaria better and has contributed directly to malaria vaccine development efforts. Here, we describe a streamlined methodology to generate transgenic Plasmodium berghei sporozoites.

Malaria is a deadly disease caused by the parasite Plasmodium and is transmitted through the bite of female Anopheles mosquitoes. The sporozoite stage of Plasmodium deposited by mosquitoes in the skin of vertebrate hosts undergoes a phase of mandatory development in the liver before initiating clinical malaria. We know little about the biology of Plasmodium development in the liver; access to the sporozoite stage and the ability to genetically modify such sporozoites are critical tools for studying the nature of Plasmodium infection and the resulting immune response in the liver. Here, we present a comprehensive protocol for the generation of transgenic Plasmodium berghei sporozoites. We genetically modify blood-stage P. berghei and use this form to infect Anopheles mosquitoes when they take a blood meal. After the transgenic parasites undergo development in the mosquitoes, we isolate the sporozoite stage of the parasite from the mosquito salivary glands for in vivo and in vitro experimentation. We demonstrate the validity of the protocol by generating sporozoites of a novel strain of P. berghei expressing the green fluorescent protein (GFP) subunit 11 (GFP11), and show how it could be used to investigate the biology of liver-stage malaria.

All research involving vertebrate animals in our laboratory was performed in compliance with the University of Georgia animal use guidelines and protocols.

1. Generation of P. berghei -infected mice

  1. Initiate blood-stage infection in male or female, 6-8-week-old C57BL/6 (B6) mice using wild-type P. berghei parasites. To do this, transfer cryopreserved P. berghei-infected blood (2 x 105 infected RBCs), reconstituted in 400 µ.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

Determining the frequency and development of schizonts is critical for assuring that enough viable parasites are in the optimal stage for transfection. Immature schizonts can be differentiated from fully mature schizonts by the presence of fewer merozoites that do not fill the entire intracellular space of the RBC (Figure 1B). It is important to note that when making blood smears from cultured blood, infected RBCs may break open, resulting in the observation of free, extracellular merozoites.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

We have used the above protocol in our laboratory to create several lines of transgenic P. berghei parasites. Though optimized for P. berghei, we have also successfully used this protocol to generate transgenic P. yoelii sporozoites. After injecting the transfected schizonts into mice, parasites are detectable typically no later than 3 d.p.i. in all groups, including the no plasmid control. Selection is started only once parasitemia has been detected to ensure the viability of parasites followi.......

Log in or to access full content. Learn more about your institution’s access to JoVE content here

  1. WHO. Geneva. World Health Organization. , 1 (2020).
  2. Cowman, A. F., Healer, J., Marapana, D., Marsh, K. Malaria: biology and disease. Cell. 167 (3), 610-624 (2016).
  3. Crompton, P. D., et al. Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annual Review of Immunology. 32, 157-187 (2014).
  4. Marques-da-Silva, C., Peissig, K., Kurup, S. P. Pre-erythrocytic vaccines against malaria. Vaccines. 8 (3), 400 (2020).
  5. Balu, B., Adams, J. H. Advancements in transfection technologies for Plasmodium. International Journal for Parasitology. 37 (1), 1-10 (2007).
  6. Rodriguez, A., Tarleton, R. L. Transgenic parasites accelerate drug discovery. Trends in Parasitology. 28 (3), 90-92 (2012).
  7. Voorberg-vander Wel, A. M., et al. A dual fluorescent Plasmodium cynomolgi reporter line reveals in vitro malaria hypnozoite reactivation. Communications Biology. 3, 7 (2020).
  8. Christian, D. A., et al. Use of transgenic parasites and host reporters to dissect events that promote interleukin-12 production during toxoplasmosis. Infection and Immunity. 82 (10), 4056-4067 (2014).
  9. Montagna, G. N., et al. Antigen export during liver infection of the malaria parasite augments protective immunity. mBio. 5 (4), e01321 (2014).
  10. Amino, R., Menard, R., Frischknecht, F. In vivo imaging of malaria parasites-recent advances and future directions. Current Opinion in Microbiology. 8 (4), 407-414 (2005).
  11. Siciliano, G., Alano, P. Enlightening the malaria parasite life cycle: bioluminescent Plasmodium in fundamental and applied research. Frontiers in Microbiology. 6, 391 (2015).
  12. Othman, A. S., et al. The use of transgenic parasites in malaria vaccine research. Expert Review of Vaccines. 16 (7), 1-13 (2017).
  13. Kreutzfeld, O., Muller, K., Matuschewski, K. Engineering of genetically arrested parasites (GAPs) for a precision malaria vaccine. Frontiers in Cellular and Infection Microbiology. 7, 198 (2017).
  14. Otto, T. D., et al. A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biology. 12, 86 (2014).
  15. Janse, C. J., Ramesar, J., Waters, A. P. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nature Protocols. 1 (1), 346-356 (2006).
  16. Tripathi, A. K., Mlambo, G., Kanatani, S., Sinnis, P., Dimopoulos, G. Plasmodium falciparum gametocyte culture and mosquito infection through artificial membrane feeding. Journal of Visualized Experiments. (161), e61426 (2020).
  17. Pacheco, N. D., Strome, C. P., Mitchell, F., Bawden, M. P., Beaudoin, R. L. Rapid, large-scale isolation of Plasmodium berghei sporozoites from infected mosquitoes. The Journal of Parasitology. 65 (3), 414-417 (1979).
  18. Kamiyama, D., et al. Versatile protein tagging in cells with split fluorescent protein. Nature Communications. 7, 11046 (2016).
  19. Bailey, J. W., et al. Guideline: the laboratory diagnosis of malaria. General Haematology Task Force of the British Committee for Standards in Haematology. British Journal of Haematology. 163 (5), 573-580 (2013).
  20. Das, D., et al. A systematic literature review of microscopy methods reported in malaria clinical trials. The American Journal of Tropical Medicine and Hygiene. 104 (3), 836-841 (2020).
  21. de Oca, M. M., Engwerda, C., Haque, A. Plasmodium berghei ANKA (PbA) infection of C57BL/6J mice: a model of severe malaria. Methods in Molecular Biology. 1031, 203-213 (2013).
  22. Musiime, A. K., et al. Is that a real oocyst? Insectary establishment and identification of Plasmodium falciparum oocysts in midguts of Anopheles mosquitoes fed on infected human blood in Tororo, Uganda. Malaria Journal. 18 (1), 287 (2019).
  23. Marques-da-Silva, C., et al. Direct type I interferon signaling in hepatocytes controls malaria. Cell Reports. 40 (3), 111098 (2022).
  24. Bowers, C., et al. Cryopreservation of Plasmodium sporozoites. Pathogens. 11 (12), 1487 (2022).
  25. Zander, R. A., et al. Th1-like plasmodium-specific memory CD4+ T cells support humoral immunity. Cell Reports. 21 (7), 1839-1852 (2017).

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

ABOUT JoVE

Copyright © 2023 MyJoVE Corporation. All rights reserved